Lessons from epidemiologic research about risk factors, modifiers, and progression of Late Onset Alzheimer’s disease in New York City at Columbia University Medical Center

Manuscript Number: 

12-9041

Author(s): 
Davangere Devanand, Joseph Lee, Jose A. Luchsinger, Jennifer Manly, Karen Marder, Richard Mayeux, Nikolaos Scarmeas, Nicole Schupf, Yaakov Stern

Disclosures

Davangere Devanand

  • Consulting Fees:
    Bristol Myers Squibb Sanofi Aventis
    Grants
    • Agency: 
      Eli Lilly
      Dates: 
      2007-current
    • Agency: 
      Novartis
      Dates: 
      2009-current

Joseph Lee

  • Nothing to Disclose

Jose A. Luchsinger

  • Consulting Fees:
    I have received Consulting honoraria from Nutricia, Inc. on the development of nutritional products for Alzheimer's disease treatment and prevention

Jennifer Manly

  • Nothing to Disclose

Karen Marder

  • Nothing to Disclose

Richard Mayeux

  • Nothing to Disclose

Nikolaos Scarmeas

  • Nothing to Disclose

Nicole Schupf

  • Nothing to Disclose

Yaakov Stern

  • Nothing to Disclose